Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: A preliminary study

Psychiatry Research - Neuroimaging

Volumn 130, Issue 3, 2004, Pages 269-281

  Brody, Arthur L ^a,b   Mandelkern, Mark A ^b,c   Lee, Grace ^b   Smith, Erlyn ^a,b   Sadeghi, Mary ^a,b   Saxena, Sanjaya ^a   Jarvik, Murray E ^a   London, Edythe D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Positron Emission Tomography Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anterior cingulate cortex; Brain metabolism; Bupropion hydrochloride; Nicotine dependence; Orbitofrontal cortex; Positron emission tomography

Indexed keywords

AMFEBUTAMONE; FLUORODEOXYGLUCOSE F 18; NICOTINE;

ADULT; AGED; ARTICLE; ASSOCIATION; ATTENTION; BRAIN METABOLISM; BRAIN RADIOGRAPHY; BRAIN SCINTISCANNING; CIGARETTE SMOKING; CINGULATE GYRUS; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCALE UP; SCORING SYSTEM; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; BUPROPION; CUES; DOPAMINE UPTAKE INHIBITORS; FEMALE; FLUORODEOXYGLUCOSE F18; GYRUS CINGULI; HUMANS; IMPULSE CONTROL DISORDERS; MAGNETIC RESONANCE IMAGING; MALE; RADIOPHARMACEUTICALS; SMOKING; TOBACCO USE DISORDER; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2342542994     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2003.12.006     Document Type: Article

References (75)

1. Bernstein L.E., Auer E.T.J., Moore J.K., Ponton C.W., Don M., Sigh M. Visual speech perception without primary auditory cortex activation. Neuroreport. 13:2002;311-315
2. Bonson K.R., Grant S.J., Contoreggi C.S., Links J.M., Metcalfe J., Weyl H.L., Kurian V., Ernst M., London E.D. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology. 26:2002;376-386
3. Brody A.L., Mandelkern M.A., London E.D., Childress A.R., Bota R.G., Ho M.L., Lee G.S., Saxena S., Baxter L.R., Madsen D., Jarvik M.E. Brain metabolic changes during cigarette craving. Archives of General Psychiatry. 59:2002;1162-1172
4. Catley D., O'Connell K.A., Shiffman S. Absentminded lapses during smoking cessation. Psychology of Addictive Behaviors. 14:2000;73-76
5. Childress A.R., Mozley P.D., McElgin W., Fitzgerald J., Reivich M., O'Brien C.P. Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry. 156:1999;11-18
6. Ciliax B.J., Drash G.W., Staley J.K., Haber S., Mobley C.J., Miller G.W., Mufson E.J., Mash D.C., Levey A.I. Immunocytochemical localization of the dopamine transporter in human brain. Journal of Comparative Neurology. 409:1999;38-56
7. Conklin C.A., Tiffany S.T., Vrana S.R. The impact of imagining completed vs. interrupted smoking on cigarette craving. Experimental and Clinical Psychopharmacology. 8:2000;68-74
8. Cooper B.R., Wang C.M., Cox R.F., Norton R., Shea V., Ferris R.M. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology. 11:1994;133-141
9. Daglish M.R., Weinstein A., Malizia A.L., Wilson S., Melichar J.K., Britten S., Brewer C., Lingford-Hughes A., Myles J.S., Grasby P., Nutt D.J. Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. American Journal of Psychiatry. 158:2001;1680-1686
10. Dazzi L., Serra M., Spiga F., Pisu M.G., Jentsch J.D., Biggio G. Prevention of the stress-induced increase in frontal cortical dopamine efflux of freely moving rats by long-term treatment with antidepressant drugs. European Neuropsychopharmacology. 11:2001;343-349
11. Dazzi L., Ladu S., Spiga F., Vacca G., Rivano A., Pira L., Biggio G. Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats. Synapse. 43:2002a;70-77
12. Dazzi L., Vignone V., Seu E., Ladu S., Vacca G., Biggio G. Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142. Journal of Psychopharmacology. 16:2002b;125-131
13. Dong J., Blier P. Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment. Psychopharmacology. 155:2001;52-57
14. Downing P.E., Jiang Y., Shuman M., Kanwisher N. A cortical area selective for visual processing of the human body. Science. 293:2001;2405-2407
15. Droungas A., Ehrman R.N., Childress A.R., O'Brien C.P. Effect of smoking cues and cigarette availability on craving and smoking behavior. Addictive Behaviors. 20:1995;657-673
16. Durcan M.J., Deener G., White J., Johnston J.A., Gonzales D., Niaura R., Rigotti N., Sachs D.P. The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clinical Therapeutics. 24:2002;540-551
17. Ernst M., Bolla K., Mouratidis M., Contoreggi C., Matochik J.A., Kurian V., Cadet J.L., Kimes A.S., London E.D. Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology. 26:2002;682-691
18. Fiore M.C., Bailey W. C., Cohen S. J., Dorfman S. F., Goldstein M. G., Gritz E. R., Heyman R. B., Jaen C. R., Kottke T. E., Lando H. A., Mecklenburg R. E., Mullen P. D., Nett L. M., Robinson L., Stitzer M. L., Tommasello A. C., Villejo L., Wewers M. E. Treating Tobacco Use and Dependence. Clinical Practice Guideline. 2000;U.S. Department of Health and Human Services. Public Health Service, Rockville, MD
19. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 1995. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, version 2.0)
20. Friston K.J., Worsley K., Frackowiak R.S.J., Mazziotta J., Evans A.C. Assessing the significance of focal activations using their spatial extent. Human Brain Mapping. 1:1994;214-220
21. Garavan H., Pankiewicz J., Bloom A., Cho J.K., Sperry L., Ross T.J., Salmeron B.J., Risinger R., Kelley D., Stein E.A. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. American Journal of Psychiatry. 157:2000;1789-1798
22. Glassman A.H. Cigarette smoking: implications for psychiatric illness. American Journal of Psychiatry. 150:1993;546-553
23. Grant S., London E.D., Newlin D.B., Villemagne V.L., Liu X., Contoreggi C.S., Phillips R.L., Kimes A.S., Margolin A. Activation of memory circuits during cue-elicited cocaine craving. Proceedings of the National Academy of Sciences of the USA. 93:1996;12 040-12 045
24. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social Psychology. 6:1967;278-296
25. Hamilton M. Diagnosis and rating of anxiety. British Journal of Psychiatary. 3:1969;76-79
26. Horst W.D., Preskorn S.H. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. Journal of Affective Disorders. 51:1998;237-254
27. Hurt R.D., Sachs D.P., Glover E.D., Offord K.P., Johnston J.A., Dale L.C., Khayrallah M.A., Schroeder D.R., Glover P.N., Sullivan C.R., Croghan I.T., Sullivan P.M. A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine. 337:1997;1195-1202
28. Jarvik M.E., Madsen, D., Shoptaw, S., Frosch, D., 1997. Ambient and outdoor carbon monoxide levels among non-smokers in Los Angeles. In: Harris, L.S. (Ed.), Problems of Drug Dependence 1996: Proceedings of the 58th Annual Scientific Meeting, the College on Problems of Drug Dependence: NIDA Research Monograph, pp. 174-210
29. Jarvik M.E., Madsen D.C., Olmstead R.E., Iwamoto-Schaap P.N., Elins J.L., Benowitz N.L. Nicotine blood levels and subjective craving for cigarettes. Pharmacology Biochemistry and Behavior. 66:2000;553-558
30. Jorenby D.E., Leischow S.J., Nides M.A., Rennard S.I., Johnston J.A., Hughes A.R., Smith S.S., Muramoto M.L., Daughton D.M., Doan K., Fiore M.C., Baker T.B. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine. 340:1999;685-691
31. Killen J.D., Fortmann S.P. Craving is associated with smoking relapse: findings from three prospective studies. Experimental and Clinical Psychopharmacology. 5:1997;137-142
32. Kilts C.D., Schweitzer J.B., Quinn C.K., Gross R.E., Faber T.L., Muhammad F., Ely T.D., Hoffman J.M., Drexler K.P.G. Neural activity related to drug craving in cocaine addiction. Archives of General Psychiatry. 58:2001;334-341
33. Levitt P., Rakic P., Goldman-Rakic P. Region-specific distribution of catecholamine afferents in primate cerebral cortex - a fluorescence histochemical analysis. Journal of Comparative Neurology. 227:1984;23-36
34. Levy L.M., Henkin R.I., Hutter A., Lin C.S., Martins D., Schellinger D. Functional MRI of human olfaction. Journal of Computer Assisted Tomography. 21:1997;849-856
35. London E.D., Ernst M., Grant S., Bonson K., Weinstein A. Orbitofrontal cortex and human drug abuse: functional imaging. Cerebral Cortex. 10:2000;334-342
36. Maas L.C., Lukas S.E., Kaufman M.J., Weiss R.D., Daniels S.L., Rogers V., Kukes T.J., Renshaw P.F. Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. American Journal of Psychiatry. 155:1998;124-126
37. Meyer J.H., Goulding V.S., Wilson A.A., Hussey D., Christensen B.K., Houle S. Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology. 163:2002;102-105
38. Michael E.B., Keller T.A., Carpenter P.A., Just M.A. FMRI investigation of sentence comprehension by eye and by ear: modality fingerprints on cognitive processes. Human Brain Mapping. 13:2001;239-252
39. Mitchell K., Oke A.F., Adams R.N. In-vivo dynamics of norepinephrine release reuptake in multiple terminal field regions of rat brain. Journal of Neurochemistry. 63:1994;917-926
40. Morgan M.J., Davies G.M., Willner P. The questionnaire of smoking urges is sensitive to abstinence and exposure to smoking-related cues. Behavioural Pharmacology. 10:1999;619-626
41. Mucha R.F., Geier A., Pauli P. Modulation of craving by cues having differential overlap with pharmacological effect: evidence for cue approach in smokers and social drinkers. Psychopharmacology. 147:1999;306-313
42. Mucha R.F., Pauli P., Angrilli A. Conditioned responses elicited by cues for smoking. Canadian Journal of Physiology and Pharmacology. 76:1998;259-268
43. Mundorf M.L., Joseph J.D., Austin C.M., Caron M.G., Wightman R.M. Catecholamine release and uptake in the mouse prefrontal cortex. Journal of Neurochemistry. 79:2001;130-142
44. Nadeau S.E., Crosson B. A guide to functional imaging of cognitive processes. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 8:1995;143-162
45. Niaura R., Abrams D., Demuth B., Pinto R., Monti P. Responses to smoking-related stimuli and early relapse to smoking. Addictive Behaviors. 14:1989a;419-428
46. Niaura R., Abrams D.B., Monti P.M., Pedraza M. Reactivity to high risk situations and smoking cessation outcome. Journal of Substance Abuse. 1:1989b;393-405
47. Nomikos G.G., Damsma G., Wenkstern D., Fibiger H.C. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology. 2:1989;273-279
48. O'Doherty J., Kringelbach M.L., Rolls E.T., Hornak J., Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nature Neuroscience. 4:2001a;95-102
49. O'Doherty J., Rolls E.T., Francis S., Bowtell R., McGlone F. Representation of pleasant and aversive taste in the human brain. Journal of Neurophysiology. 85:2001b;1315-1321
50. Page M.E., Lucki I. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex. Neuropsychopharmacology. 27:2002;237-247
51. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach coordinate system. Cerebral Cortex. 5:1995;323-337
52. Sayette M.A., Hufford M.R. Effects of cue exposure and deprivation on cognitive resources in smokers. Journal of Abnormal Psychology. 103:1994;812-818
53. Schuh K.J., Stitzer M.L. Desire to smoke during spaced smoking intervals. Psychopharmacology. 120:1995;289-295
54. Sell L.A., Morris J.S., Bearn J., Frackowiak R.S., Friston K.J., Dolan R.J. Neural responses associated with cue evoked emotional states and heroin in opiate addicts. Drug and Alcohol Dependence. 60:2000;207-216
55. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. Journal of Neuroscience. 18:1998;2697-2708
56. Settle E.C., Stahl S.M., Batey S.R., Johnston J.A., Ascher J.A. Safety profile of sustained-release bupropion in depression: results of three clinical trials. Clinical Therapeutics. 21:1999;454-463
57. Shiffman S., Johnston J.A., Khayrallah M., Elash C.A., Gwaltney C.J., Paty J.A., Gnys M., Evoniuk G., DeVeaugh-Geiss J. The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology. 148:2000;33-40
58. Shiffman S.M., Jarvik M.E. Smoking withdrawal symptoms in 2 weeks of abstinence. Psychopharmacology. 50:1976;35-39
59. Steinmetz H., Seitz R.J. Functional anatomy of language processing: neuroimaging and the problem of individual variability. Neuropsychologia. 29:1991;1149-1161
60. Swan G.E., Ward M.M., Jack L.M. Abstinence effects as predictors of relapse in smokers. Addictive Behaviors. 21:1996;481-490
61. Sweeney C.T., Pillitteri J.L., Kozlowski L.T. Measuring drug urges by questionnaire. Addictive Behaviors. 21:1996;199-204
62. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. 1988;Thieme, New York, NY
63. Takada M., Hattori T. Organization of ventral tegmental area cells projecting to the occipital cortex and forebrain in the rat. Brain Research. 418:1987;27-33
64. Taylor R.C., Harris N.A., Singleton E.G., Moolchan E.T., Heishman S.J. Tobacco craving: intensity-related effects of imagery scripts in drug abusers. Experimental and Clinical Psychopharmacology. 8:2000;75-87
65. Tsoh J.Y., Humfleet G.L., Munoz R.F., Reus V.I., Hartz D.T., Hall S.M. Development of major depression after treatment for smoking cessation. American Journal of Psychiatry. 157:2000;368-374
66. Volkow N.D., Fowler J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereberal Cortex. 10:2000;318-325
67. Volkow N.D., Fowler J.S., Wolf A.P., Hitzemann R., Dewey S., Bendriem B., Alpert R., Hoff A. Changes in brain glucose metabolism in cocaine dependence and withdrawal. American Journal of Psychiatry. 148:1991;621-626
68. Volkow N.D., Wang G.J., Fowler J.S., Hitzemann R., Angrist B., Gatley S.J., Logan J., Ding Y.S., Pappas N. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. American Journal of Psychiatry. 156:1999;19-26
69. Wexler B.E., Gottschalk C.H., Fulbright R.K., Prohovnik I., Lacadie C.M., Rounsaville B.J., Gore J.C. Functional magnetic resonance imaging of cocaine craving. American Journal of Psychiatry. 158:2001;86-95
70. Whatmough C., Chertkow H., Murtha S., Hanratty K. Dissociable brain regions process object meaning and object structure during picture naming. Neuropsychologia. 40:2002;174-186
71. Williams S.M., Goldman-Rakic P.S. Widespread origin of the primate mesofrontal dopamine system. Cereberal Cortex. 8:1998;321-345
72. Woods R.P., Mazziotta J.C., Cherry S.R. MRI-PET registration with automated algorithm. Journal of Computer Assisted Tomography. 17:1993;536-546
73. Zald D.H., Lee J.T., Fluegel K.W., Pardo J.V. Aversive gustatory stimulation activates limbic circuits in humans. Brain. 121:1998;1143-1154
74. Zald D.H., Pardo J.V. Emotion, olfaction, and the human amygdala: amygdala activation during aversive olfactory stimulation. Proceedings of the National Academy of Sciences of the Unites States of America. 94:1997;4119-4124
75. Zatorre R.J., Jonesgotman M., Evans A.C., Meyer E. Functional localization and lateralization of human olfactory cortex. Nature. 360:1992;339-340